Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diaphanous-related formin 1 (mDia1) is a member of the formin protein family and acts as a key regulator of the actin cytoskeleton in eukaryotic cells. It functions as an effector for Rho GTPases and is essential for actin filament nucleation, elongation, and organization. mDia1 forms dimers that processively cap growing actin filaments and is autoinhibited by intramolecular interaction between its N-terminal and C-terminal domains, a process relieved by Rho GTPase binding. Through these activities, mDia1 is critical in cellular processes such as stress fiber and filopodia formation, cytokinesis, cell migration, and cellular response to extracellular signals. It also contributes to phagocytosis and microtubule stabilization, and through regulation of actin dynamics, indirectly modulates transcription via serum response factor (SRF) activation. Dysregulation of mDia1 has implications in cancer and development due to its control of cytoskeletal remodeling and cell movement.
Actin nucleation by interaction with barbed ends of actin filaments Relief of autoinhibition through Rho GTPase binding, promoting actin assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diaphanous-related formin 1 (mDia1).